Elutia company information, Employees & Contact Information

Elutia Appoints Guido J. Neels To Board citybiz

Oct 21 presentation: Elutia (ELUT) CEO Randy Mills to present at LD Micro Main Event; webcast 1:00 PM PT Stock Titan

Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million Yahoo Finance

Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 The Manila Times

Medical Device Network Excellence Awards 2025: Elutia Medical Device Network

Elutia Inc. Appoints Guido J. Neels to Board of Directors, Strengthening Leadership in Medical Technology Quiver Quantitative

Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21 MarketScreener

Elutia Inc. Announces Promising Study Results for EluPro BioEnvelope in Improving Healing Outcomes for Cardiac Implantable Electronic Devices Nasdaq

Elutia Inc. Completes $88 Million Sale of BioEnvelope Business to Focus on NXT-41x Development for Breast Reconstruction Quiver Quantitative

Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million citybiz

$88M Deal: Elutia Sells BioEnvelope to Boston Scientific, Targets $1.5B Breast Reconstruction Market Stock Titan

Elutia closes $88M bioenvelope sale to Boston Scientific Drug Delivery Business

Leading Biomatrix Tech Company Elutia Set for Major Wall Street Conference Circuit This September Stock Titan

43% Easier Heart Device Reoperations: Elutia's Breakthrough Envelope Technology Shows Major Clinical Success Stock Titan

First-Ever FDA-Cleared Antibiotic-Eluting BioEnvelope: Elutia's EluPro to Transform Cardiac Device Surgery Stock Titan

Healthcare Milestone: Elutia Secures 7th GPO Deal for Revolutionary Antibiotic Device Stock Titan

Boston Scientific inks $88M Elutia deal to challenge Medtronic MedTech Dive

Boston Scientific to purchase Elutia’s drug-eluting envelope business for $88M Cardiovascular Business

Elutia to divest bioenvelopes business to Boston Scientific for $88m Medical Device Network

Gaithersburg’s Elutia selling key business line to Boston Scientific, sets sights on new products The Business Journals

Elutia sells drug-eluting bioenvelope tech to Boston Scientific for $88M Drug Delivery Business

Elutia to Sell BioEnvelope Business to Boston Scientific for $88M The Healthcare Technology Report.

Medical Device Maker Elutia Sees Record Growth as New EluPro Product Captures Hospital Market Share Stock Titan

Elutia closes $88M bioenvelope sale to Boston Scientific MassDevice

EluPro CIED Antibiotic-Eluting BioEnvelope: Feel the Difference Biology Makes HMP Global Learning Network

Elutia sells drug-eluting bioenvelope tech to Boston Scientific for $88M MassDevice

Boston Sci acquires Elutia's bioenvelopes for $88M BioWorld MedTech

Elutia sells BioEnvelope business to Boston Scientific for $88 million DOTmed

Boston Sci closes Elutia deal, projects 10% growth through 2028 BioWorld MedTech

Elutia v. Medtronic: Delaware court rules on indemnity and insurance obligations in FiberCel lawsuit Insurance Business America

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations citybiz

Elutia Announces FDA Clearance of EluPro: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators Diagnostic and Interventional Cardiology

Boston Scientific buys Elutia's bioenvelope business for $88 million MSN

ELUT Stock Price and Chart — NASDAQ:ELUT TradingView